The big winner in 2018 was Amarin. Was Vascepa in the Evaluate list for 2018?
In most industries, it is the out of left field players that make it big. I am wiling to bet that it will be Apabetalone for 2019. It ticks all boxes...probably just like Vascepa did in January 2018.